Shashank S Ghantoji

Shashank S Ghantoji

UNVERIFIED PROFILE

Are you Shashank S Ghantoji?   Register this Author

Register author
Shashank S Ghantoji

Shashank S Ghantoji

Publications by authors named "Shashank S Ghantoji"

Are you Shashank S Ghantoji?   Register this Author

20Publications

491Reads

24Profile Views

Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.

J Med Virol 2020 Jan 3;92(1):86-95. Epub 2019 Sep 3.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.25574DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842396PMC
January 2020

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.

J Antimicrob Chemother 2018 11;73(11):3162-3169

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dky311DOI Listing
November 2018

Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms.

BMC Infect Dis 2017 10 10;17(1):672. Epub 2017 Oct 10.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1460, Houston, TX, 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-017-2792-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635568PMC
October 2017

Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.

J Antimicrob Chemother 2016 Mar 26;71(3):727-30. Epub 2015 Nov 26.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1460, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkv393DOI Listing
March 2016

Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting.

Infect Control Hosp Epidemiol 2015 Dec 2;36(12):1461-3. Epub 2015 Sep 2.

3Xenex Disinfection Services,LLC,San Antonio,Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2015.208DOI Listing
December 2015

Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members.

Infect Control Hosp Epidemiol 2015 Oct 1;36(10):1239-41. Epub 2015 Jul 1.

Department of Infectious Diseases,Infection Control and Employee Health,University of Texas MD Anderson Cancer Center,Houston,Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2015.150DOI Listing
October 2015

Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013.

J Infect Dis 2015 Feb 25;211(4):582-9. Epub 2014 Aug 25.

Department of Molecular Virology and Microbiology Department of Pediatrics, Baylor College of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiu473DOI Listing
February 2015

The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer.

Pharmacotherapy 2014 Nov 28;34(11):1220-5. Epub 2014 Aug 28.

Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1479DOI Listing
November 2014

Respiratory syncytial virus infections in children with cancer.

J Pediatr Hematol Oncol 2014 Aug;36(6):e376-81

Departments of *Infectious Diseases, Infection Control, and Employee Health ‡Stem Cell Transplantation and Cellular Therapy §Pediatrics, The University of Texas MD Anderson Cancer Center †Department of Neurology, Baylor College of Medicine, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000086DOI Listing
August 2014

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.

Blood 2014 May 3;123(21):3263-8. Epub 2014 Apr 3.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-12-541359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046424PMC
May 2014

Management of respiratory viral infections in hematopoietic cell transplant recipients.

Am J Blood Res 2012 25;2(4):203-18. Epub 2012 Nov 25.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center Houston, TX, USA ; The University of Texas School of Public Health, Houston TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512176PMC
December 2012

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation.

Blood 2012 Mar 12;119(12):2738-45; quiz 2969. Epub 2012 Jan 12.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-08-371112DOI Listing
March 2012